{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T07:14:00Z","timestamp":1772435640796,"version":"3.50.1"},"reference-count":35,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2169\/internalmedicine.52.9430","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T23:36:47Z","timestamp":1375313807000},"page":"1665-1673","source":"Crossref","is-referenced-by-count":7,"title":["Association of Visceral Obesity with High Viral Load and Histological Findings in Elderly Patients with Genotype 1 Chronic Hepatitis C"],"prefix":"10.2169","volume":"52","author":[{"given":"Hironori","family":"Tsuzura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Genda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuharu","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Kanemitsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyori","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Pathology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ichida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Juntendo University Shizuoka Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567, 2005.","DOI":"10.1016\/S1473-3099(05)70216-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lauer G, Walker BD. Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001.","DOI":"10.1056\/NEJM200107053450107"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 137: 961-964, 2002.","DOI":"10.7326\/0003-4819-137-12-200212170-00009"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Asselah T, Rubbia- Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut 55: 123-130, 2006.","DOI":"10.1136\/gut.2005.069757"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Camma C, Bruno S, Di Marco V, et al. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43: 64-71, 2006.","DOI":"10.1002\/hep.20983"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Petta S, Camma C, Di Marco V, et al. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 103: 1136-1144, 2008.","DOI":"10.1111\/j.1572-0241.2008.01813.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29: 1215-1219, 1999.","DOI":"10.1002\/hep.510290401"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Adinofi LE, Gamdardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358-1364, 2001.","DOI":"10.1053\/jhep.2001.24432"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Patton HM, Patel K, Behling C, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 40: 484-490, 2004.","DOI":"10.1016\/j.jhep.2003.11.004"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128: 636-641, 2005.","DOI":"10.1053\/j.gastro.2004.12.049"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sato S, Genda T, Hirano K, et al. Differences in the factors associated with serum viral load between genotype 1 and 2 in patients with chronic hepatitis C. Hepatol Int 2011: epub ahead of print.","DOI":"10.1007\/s12072-011-9273-z"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556, 2004.","DOI":"10.1210\/jc.2004-0395"},{"key":"13","unstructured":"13. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 128: 636-641, 2005."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444: 881-887, 2006.","DOI":"10.1038\/nature05488"},{"key":"15","unstructured":"15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: finding from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kobayashi J, Nishimura K, Matoba M, Maekawa N, Mabuchi H. Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circ J 71: 1734-1737, 2007.","DOI":"10.1253\/circj.71.1734"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sakurai T, Iimuro S, Araki A, et al. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA \/ NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 Diabetes Mellitus. Gerontology 56: 141-149, 2010.","DOI":"10.1159\/000246970"},{"key":"18","unstructured":"18. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology 211: 283-286, 1999."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 79: 474-481, 2008.","DOI":"10.1016\/j.diabres.2007.10.016"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb 12: 301, 2005.","DOI":"10.5551\/jat.12.301"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"22","unstructured":"22. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Poynald T, Bedossa P, Opoion P. Natural history of liver fibrosis in patients with chronic hepatitis C. Lancet 349: 825-832, 1997.","DOI":"10.1016\/S0140-6736(96)07642-8"},{"key":"24","unstructured":"24. Hadziyannis SJ, Sette H, Morgan TR, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: randomized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355, 2004."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Gordon SC, Dailey PJ, Silverman AL, Khan BA, Kodali VP, Wilber JC. Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification. Hepatlogy 28: 1702-1706, 1998.","DOI":"10.1002\/hep.510280634"},{"key":"26","unstructured":"26. Yoshimura E, Hayashi J, Ueno K, et al. No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection. Dig Dis Sci 42: 772-777, 1997."},{"key":"27","unstructured":"27. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotype 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134: 416-423, 2008."},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Hsu CS, Liu CH, Liu CJ, et al. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Am J Gastroenterol 104: 598-604, 2009.","DOI":"10.1038\/ajg.2008.125"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Petta S, Amato M, Cabibi D, et al. Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 52: 1543-1552, 2010.","DOI":"10.1002\/hep.23859"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Chayama K, Hayes CN, Yoshioka K, et al. Accumulation of refractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatol Res 40: 1155-1167, 2010.","DOI":"10.1111\/j.1872-034X.2010.00726.x"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Kobayashi M, Suzuki F, Akuta N, et al. Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C Virus. J Gastroenterol 47: 834-844, 2012.","DOI":"10.1007\/s00535-012-0531-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yoneda M, Saito S, Ikeda T, et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabeic patients. J Viral Hepat 14: 600-607, 2007.","DOI":"10.1111\/j.1365-2893.2006.00836.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Park BJ, Kim YJ, Kim DH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 23: 900-907, 2008.","DOI":"10.1111\/j.1440-1746.2007.05212.x"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gonzalez-Reimers E, Castellano-Higuera A, Aleman-Valls R, et al. Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection. Ann Nutr Metab 55: 351-357, 2009.","DOI":"10.1159\/000252351"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Palmer C, Hampartzoumian T, Lioyd A, Zekry A. A novel role for adiponectin in regulating the immune responses in chronic hepatitis C virus infection. Hepatology 48: 374-384, 2008.","DOI":"10.1002\/hep.22387"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.9430\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:49:40Z","timestamp":1621446580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/52\/15\/52_52.9430\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.52.9430","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}